Amanote Research
Register
Sign In
Discover open access scientific publications
Search, annotate, share and cite publications
Publications by Iain K Robertson
The Lipid Lowering and Onset of Renal Disease (LORD) Trial: A Randomized Double Blind Placebo Controlled Trial Assessing the Effect of Atorvastatin on the Progression of Kidney Disease
BMC Nephrology
Nephrology
Related publications
Etanercept in Alzheimer Disease: A Randomized, Placebo-Controlled, Double-Blind, Phase 2 Trial
Neurology
Neurology
Randomized, Double-Blind, Placebo-Controlled Trial on Symptomatic Effects of Coenzyme Q10 in Parkinson Disease
Archives of Neurology
Journal Club: A Randomized, Double-Blind, Placebo-Controlled Trial of Simvastatin to Treat Alzheimer Disease
Neurology
Neurology
The Effect of Aggressive Versus Standard Lipid Lowering by Atorvastatin on Diabetic Dyslipidemia: The DALI Study: A Double-Blind, Randomized, Placebo-Controlled Trial in Patients With Type 2 Diabetes and Diabetic Dyslipidemia
Diabetes Care
Internal Medicine
Endocrinology
Advanced
Metabolism
Specialized Nursing
Diabetes
Effect of Chlorogenic Acids on Cognitive Function: A Randomized, Double-Blind, Placebo-Controlled Trial
Nutrients
Nutrition
Food Science
Dietetics
Effect of Lactocare® Synbiotic on Disease Severity in Ulcerative Colitis: A Randomized Placebo-Controlled Double-Blind Clinical Trial
Middle East Journal of Digestive Diseases
Hepatology
Gastroenterology
A Randomized Double-Blind Placebo Controlled Trial of Oral Acyclovir in Renal Allograft Recipients
Canadian Journal of Infectious Diseases
Aripiprazole for the Treatment of Methamphetamine Dependence: A Randomized, Double-Blind, Placebo-Controlled Trial
Addiction
Medicine
Psychiatry
Mental Health
Octreotide-Lar in Later-Stage Autosomal Dominant Polycystic Kidney Disease (ALADIN 2): A Randomized, Double-Blind, Placebo-Controlled, Multicenter Trial
PLoS Medicine
Biochemistry
Biotechnology
Molecular Biology
Cell Biology
Medicine
